Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02141828
Title A Phase 1 Dose Escalation and Expanded Cohort Study of EPZ-5676 in the Treatment of Pediatric Patients With Relapsed/Refractory Leukemias Bearing a Rearrangement of the MLL Gene
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Epizyme, Inc.
Indications
Therapies
Age Groups: child
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Childrens Hospital Los Angeles Los Angeles California 90027 United States Details
University of California San Francisco Medical Center-Parnassus San Francisco California 94143 United States Details
Children's Hospital Colorado Aurora Colorado 80045 United States Details
Emory Children's Healthcare of Atlanta Atlanta Georgia 30322 United States Details
Johns Hopkins University Baltimore Maryland 21287 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 United States Details
The Hospital for Sick Kids Toronto Ontario Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field